ongoing Research

The Center is involved in several projects evaluating the concept of value-based insurance design, including:

  • Evaluating the Impact of Comparative Effectiveness Research on Patient Access to Biopharmaceutical Healthcare Technologies.

  • An evaluation of a comprehensive reduction of copayments for recommended clinical services for University of Michigan employees with a diagnosis of diabetes mellitus.
  • Evaluation of a V-BID implementation for heart disease prevention by Health Alliance Medical Plan.
  • Universal American Evaluation.
  • Impact of Medicare Part D coverage on hospital admissions for Medicare beneficiaries.
  • Impact of an incentive-based wellness program on hospital admissions.
  • Evaluation on Alternative Quality Contract in Massachusetts.
  • Assessment of geographic variation in prescription drugs.
  • Effect of generic drug availability on long term adherence.
  • Effect of patient-level cost-sharing on employee productivity.
  • Comparison of price elasticity for drugs prescribed for symptomatic and non-symptomatic conditions.

The Facts

Americans receive only about half of recommended care, and quality varies significantly by clinical condition.

"The alignment of financial incentives – for patients and providers – would encourage the use of high-value care, while discouraging the use of low-value or unproven services, and ultimately produce more health at any level of health care expenditure.”

- A. Mark Fendrick
Center for V-BID